购物车
全部删除
您的购物车当前为空
CDK8-IN-11 是一种具有选择性和高效性的 CDK8 抑制剂,对结肠癌细胞系显示出抗增殖活性,抑制 WNT/β-catenin 的激活和 TCF 家族的转录活性,诱导 HCT-116 细胞阻滞 G1 期,可用于研究结肠癌。

CDK8-IN-11 是一种具有选择性和高效性的 CDK8 抑制剂,对结肠癌细胞系显示出抗增殖活性,抑制 WNT/β-catenin 的激活和 TCF 家族的转录活性,诱导 HCT-116 细胞阻滞 G1 期,可用于研究结肠癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 497 | 现货 | |
| 5 mg | ¥ 1,230 | 现货 | |
| 10 mg | ¥ 1,980 | 现货 | |
| 25 mg | ¥ 4,560 | 现货 | |
| 50 mg | ¥ 6,390 | 现货 | |
| 100 mg | ¥ 8,620 | 现货 | |
| 200 mg | ¥ 11,600 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,360 | 现货 |
CDK8-IN-11 相关产品
| 产品描述 | CDK8-IN-11 is a selective and potent CDK8 inhibitor that shows antiproliferative activity in colon cancer cell lines, inhibiting WNT/β-catenin activation and TCF family transcriptional activity, inducing G1-phase arrest in HCT-116 cells, useful for colon cancer research. |
| 靶点活性 | CDK8:46 nM |
| 体外活性 | CDK8-IN-11 对 CDK8 具有很强的选择抑制活性, IC50 值为 46 nM。 |
| 体内活性 | 在 CT-26 异种移植小鼠模型中, CDK8-IN-11(10 和 40 mg/kg, p.o)能够抑制肿瘤的生长。[1] |
| 分子量 | 388.34 |
| 分子式 | C19H15F3N4O2 |
| CAS No. | 2839338-28-0 |
| Smiles | O=C(NC1=CC=C(OC2=CN=C(N)C=C2)C=C1)NC3=CC=CC(=C3)C(F)(F)F |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200 mg/mL (515.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容